Replies to post #13449 on Marker Therapeutics Inc (MRKR)

[lasers]

IMO a $TPIV P2B pivotal clinical trial JV with a Major Pharma is most likely in the near future as a Combo to increase the ORR of the Pharma's HER2/neu FDA Commercially approved or late stage successful drug.